Incannex Healthcare Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · Australia
Last price 2.58 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 32.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn’s disease. The company is headquartered in Melbourne, Australia.
Details
| Name | Incannex Healthcare Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 12 |
| Founded | 2001 |
| Ceo | Joel Latham |
| Country | Australia |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| Ipo Price | 9.38 |
| Isin | US45333F2083 |
| Cusip | 45333F208 |
| Cik | 1873875 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| John Michailidis B.Sc., EMBA, M.A.I.C.D. | Chief Executive Officer of IncannexTM |
| Joel Bradley Latham | President, Chief Executive Officer and Executive Director |
| Joseph Swan | Chief Financial Officer, Treasurer and Secretary |
| Dr. Luigi M. Barbato M.D. | Chief Medical Officer |
| Lekhram Changoer M.Sc. | Chief Technology Officer |
| Dr. Mark Bleackley Ph.D. | Chief Scientific Officer, Head of Programs and Member of the Advisory Board |
| Natalie May | Head of Clinical Operations |
Contact
| Address | Rialto South Tower Level 23, 525 Collins Street, Melbourne, VIC 2153, Australia |
| Phone | 61 4 0984 0786 |
| Website | https://www.incannex.com |